To investigate the anti-tumor effect of DAPK2, we first detected the expression of DAPK2 in 9 CRC cell lines includingHCT15, RKO, DLD1, HCT116, NUM460, HT29, SW1116, HCT8, SW480, and SW620. This evidence concerns the gene DAPK2 and colorectal carcinoma.